Marseille, France

Nathalie Bardin

This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: National Institute of Health and Medical Research, Université´ D'aix-Marseille, Assistance Publique Hopitaux De Marseille. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nathalie Bardin. Retrieved from https://idiyas.com/inventor/nathalie-bardin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Nathalie Bardin: Innovating in Cancer Treatment and Human Fertility**

Introduction

Nathalie Bardin is a groundbreaking inventor based in Marseilles, France, known for her significant contributions to the fields of cancer diagnosis and treatment, as well as human fertility. With a total of four patents to her name, she has dedicated her research to developing innovative solutions that have the potential to change lives.

Latest Patents

Bardin's latest patents showcase her expertise and commitment to advancing medical science. One of her notable inventions is related to Anti-CD146 antibodies and their applications, which addresses the diagnostic and treatment needs for various cancers, including melanoma, pancreatic cancer, kidney cancer, and colon cancer. This invention focuses on developing an antibody that specifically targets CD146-positive tumors, enabling its use as a medicament for cancer prevention and treatment, as well as for diagnostic or prognostic purposes.

Another pivotal patent revolves around the use of soluble CD146 as a biomarker to select in vitro-fertilized embryos for implantation in mammals. This invention identifies soluble CD146 (sCD146) in embryo culture medium, allowing practitioners to determine which embryos are suitable for implantation in the uterus. This innovation not only enhances fertility treatment but also provides new methods for promoting pregnancy during embryo transfer.

Career Highlights

Bardin has a distinguished career, working with prominent institutions such as Université D'Aix-Marseille and the Institut National de la Santé et de la Recherche Médicale (INSERM). Her work in these organizations underscores her dedication to research and innovation in medical science, contributing to both academic and practical applications.

Collaborations

Throughout her career, Nathalie Bardin has collaborated with esteemed colleagues, including Marcel Blot-Chabaud and Benjamin Guillet. These collaborations have facilitated the exchange of ideas and have fostered an environment conducive to groundbreaking advancements in their shared fields of study.

Conclusion

Nathalie Bardin is a trailblazer in the fields of cancer research and fertility treatment. With her innovative patents and impactful collaborations, she continues to advance our understanding and treatment of complex medical conditions. Her work serves as an inspiration for future inventors and researchers aiming to make a difference in the world.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…